Vaccine Industry Consultation 2026
20–22 October 2026 in Copenhagen
Across more than 190 countries and territories, UNICEF does whatever it takes to help children survive, thrive and reach their full potential. UNICEF operates on five continents, supporting governments to reduce and ultimately eliminate mortality and morbidity associated with vaccine-preventable diseases, and give children a fair chance to reach their full potential.
To maximize results for children, UNICEF partners with and acts as procurement agency for several initiatives, including Gavi, the Vaccine Alliance, the Measles and Rubella Partnership, and the Global Polio Eradication Initiative.
UNICEF has a key role in the procurement of vaccines and immunization supplies on behalf of more than 100 countries. UNICEF is the world’s largest buyer of vaccines, delivering three billion doses of vaccines every year, enough to immunize nearly half of the world’s children under five.
The 2026 Vaccine Industry Consultation took place on 20–22 October in Copenhagen, covering key vaccine markets including pneumococcal, rotavirus, human papillomavirus, malaria, measles-containing, yellow fever, meningococcal, polio, and new and emerging vaccines.
The sessions included updates on the immunization landscape in 2026 and beyond, as well as a number of cross-cutting topics.
For more information, please contact [email protected].
Explore also:
Vaccine Industry Consultation 2026 Agenda (PDF file)
